Abbisko Therapeutics Co., Ltd.
Records under this name other than the patents Abbisko Therapeutics Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 14 patents it holds.
Showing 1 to 2 of 2 · Back to Abbisko Therapeutics Co., Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,180,495 | Nitrogen heteroaryl derivative having CSF1R inhibitory activity, and preparation method therefor and application thereof Lapsed on the fee record Ended Nov 23, 2025 · USPTO record | Lapsed on the fee record | Ended Nov 23, 2025 | USPTO record |
| US 11,130,762 | Azaaryl derivative, preparation method therefor, and application thereof for use in pharmacy Lapsed on the fee record Ended Sep 28, 2025 · USPTO record | Lapsed on the fee record | Ended Sep 28, 2025 | USPTO record |